467
Participants
Start Date
May 22, 2017
Primary Completion Date
July 9, 2019
Study Completion Date
January 27, 2020
Evolocumab
Dose of subcutaneous evolocumab QM
Placebo
Dose of matching placebo QM
Research Site, Brussels
Research Site, Lausanne
Research Site, Geneva
Research Site, Antwerp
Research Site, Darlinghurst
Research Site, East Sydney
Research Site, Sydney
Research Site, Westdene
Research Site, Melbourne
Research Site, Prahran
Research Site, Fortitude Valley
Research Site, Lugano
Research Site, Zurich
Research Site, Ghent
Research Site, Bloemfontein
Research Site, New York
Research Site, The Bronx
Research Site, Athens
Research Site, Athens
Research Site, Albany
Research Site, Athens
Research Site, Athens
Research Site, Genova
Research Site, Washington D.C.
Research Site, Washington D.C.
Research Site, Washington D.C.
Research Site, Milan
Research Site, Falls Church
Research Site, Madrid
Research Site, Madrid
Research Site, Augusta
Research Site, Vero Beach
Research Site, Bordeaux
Research Site, Miami
Research Site, Tampa
Research Site, Montpellier
Research Site, Bologna
Research Site, Modena
Research Site, Nantes
Research Site, Cincinnati
Research Site, Berkley
Research Site, Southfield
Research Site, Detroit
Research Site, Thessaloniki
Research Site, Minneapolis
Research Site, Pisa
Research Site, St Louis
Research Site, Lyon
Research Site, Paris
Research Site, Paris
Research Site, Paris
Research Site, Los Angeles
Research Site, Timișoara
Research Site, Brasov
Research Site, Constanța
Research Site, Hartford
Research Site, Camden
Research Site, São Paulo
Research Site, Rio de Janeiro
Research Site, São Paulo
Research Site, Calgary
Research Site, Vancouver
Research Site, Hamilton
Research Site, Montreal
Research Site, Québec
Research Site, Roma
Research Site, Warsaw
Research Site, Almada
Research Site, Aveiro
Research Site, Coimbra
Research Site, Porto
Research Site, Bucharest
Research Site, Pretoria
Research Site, Barcelona
Research Site, Barcelona
Research Site, London
Research Site, London
Research Site, London
Lead Sponsor
Amgen
INDUSTRY